×
Chemed Receivables 2010-2024 | CHE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Chemed receivables for the quarter ending June 30, 2024 were
$0.185B
, a
53.73% increase
year-over-year.
Chemed receivables for 2023 were
$0.182B
, a
30.2% increase
from 2022.
Chemed receivables for 2022 were
$0.139B
, a
1.6% increase
from 2021.
Chemed receivables for 2021 were
$0.137B
, a
8.17% increase
from 2020.
View More
Chemed Receivables 2010-2024 | CHE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Chemed receivables for 2023 were
$0.182B
, a
30.2% increase
from 2022.
Chemed receivables for 2022 were
$0.139B
, a
1.6% increase
from 2021.
Chemed receivables for 2021 were
$0.137B
, a
8.17% increase
from 2020.
Related Stocks
Company Name
Market
Cap
Fresenius SE (FSNUY)
$21.4B
Quest Diagnostics (DGX)
$17.3B
DaVita (DVA)
$13.7B
Encompass Health (EHC)
$9.3B
Elanco Animal Health (ELAN)
$7.2B
Option Care Health (OPCH)
$5.3B
RadNet (RDNT)
$5B
Amedisys (AMED)
$3.2B
Astrana Health (ASTH)
$2.8B
LifeStance Health (LFST)
$2.6B
Addus HomeCare (ADUS)
$2.4B
U.S Physical Therapy (USPH)
$1.3B
Pennant (PNTG)
$1.1B
Aveanna Healthcare Holdings (AVAH)
$1B
Atai Life Sciences (ATAI)
$208M
Daxor (DXR)
$45M
ATI Physical Therapy (ATIP)
$25M
MEDIROM Healthcare Technologies (MRM)
$19M
Psychemedics (PMD)
$14M
Ontrak (OTRK)
$10M
Novo Integrated Sciences (NVOS)
$6M
IMAC Holdings (BACK)
$2M